NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

One glaring problem that became even more glaring at the ASM is the lack of any investor relationship strategy or capability. Les might be a fine lawyer, but he has not done well in waring the hat of the IR representative.

The hiring of a new IR person is positive and consistent with their outlook that accretive news will unfolded sooner rather than later.

Your position doesn't make sense. They are doing these things just fine on their own. Why would they need a new salaried position to continue what they are already doing? No, this is a new direction, imo. Looks like a real effort to boost share price, which I support 100 percen